Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication

Antiviral Chemistry and Chemotherapy

Volumn 13, Issue 1, 2002, Pages 39-59

  Barnard, Dale L ^a   Xu, Ze Qi ^b   Stowell, Valerie D ^a   Yuan, Hongwei ^b   Smee, Donald F ^a   Samy, Raghu ^b   Sidwell, Robert W ^a   Nielsen, M Kim ^c   Sun, Lihui ^b   Cao, Hua ^b   Li, Ailing ^b   Quint, Clay ^b   Deignan, Jeffrey ^b   Crabb, Jennifer ^b   Flavin, Michael T ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b MediChem Research Inc   (United States)

^c Cache Valley Specialty Hospital   (United States)

Author keywords

Antiviral; Benzodipyranone; Benzotripyranone; Coumarin; Inhibition; Measles virus; Pyranocoumarin; Structure activity relationships

Indexed keywords

4 PROPYL 6,6,10,11 TETRAMETHYL 7,8,9 TRIHYDROXY 2H,6H,12H BENZO[1,2 B:3,4 B':5,6 B'']TRIPYRAN 2 ONE; 5 HYDROXY 4 PROPYL 7 TOSYLOXYCOUMARIN; 5 HYDROXY 7 PROPIONYLOXY 4 PROPYLCOUMARIN; 5,7 BIS(TOSYLOXY) 4 PROPYLCOUMARIN; 6,6 DIMETHYL 9 PIVALOYLOXY 4 PROPYL 2H,6H BENZO[1,2 B:3,4 B']DIPYRAN 2 ONE; 6,6 DIMETHYL 9 PROPIONYLOXY 4 PROPYL 2H,6H BENZO[1,2 B:3,4 B']DIPYRAN 2 ONE; COUMARIN DERIVATIVE; PYRANOCOUMARIN DERIVATIVE; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0036462251     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020201300104     Document Type: Article

References (42)

1. Afzal MA, Minor PD & Schild GC (2000) Clinical safety issues of measles, mumps and rubella vaccines. Bulletin of the World Health Organisation 78:199-204.
2. Barnard DL, Bischofberger N, Kim CU, Huffman JH, Sidwell RW, Dougherty JP, Lew W, Williams MA & Yang W (1997a) Acyclic phosphonomethylether nucleoside inhibitors of respiratory viruses. Antiviral Chemistry & Chemotherapy 8:223-233.
3. Barnard DL, Hill CL, Gage TL, Matheson JL, Huffman JH, Sidwell RW, Otto MJ & Schinazi RF (1997b) Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. Antiviral Research 34:27-37.
4. Barnard DL, Sidwell RW, Xiao W, Player MR, Adah S & Torrence PF (1999) 2-5A-antisense inhibition of respiratory syncytial virus replication: Effects of oligonucleotide structure modifications and RNA target site selection. Antiviral Research 41:119-134.
5. Barnard DL, Stowell VD, Seley KL, Hegde VR, Das SR, Rajappan VP, Schneller SW, Smee DF & Sidwell RW (2001) Inhibition of measles virus replication by 5′-nor carbocyclic adenosine analogues. Antiviral Chemistry & Chemotherapy 12:221-230.
6. Bell D, Davies MR, Geen GR & Mann IS (1995) Copper(I) iodide: a catalyst for the improved synthesis of aryl propargyl ethers. Synthesis 707-712.
7. Bellini WJ & Rota PA (1998) Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerging Infectious Diseases 4:29-35.
8. Bourinbaiar AS, Tan X & Nagorny R (1993) Inhibitory effect of coumarins on HIV-1 replication and cell-mediated or cell-free viral transmission. Acta Virologica 37:241-250.
9. Cavenaugh PR Jr, Moskwa PS, Donish WH, Pera PJ, Richardson D & Andrese AP (1990) A semi-automated NR red based chemosensitivity assay for drug screening. Investigational New Drugs 8:347-354.
10. Chenera B, West ML, Finkelstein JA & Dreyer GB (1993) Total synthesis of (±)-calanolide A, a non-nucleoside inhibitor of hiv-1 reverse transcriptase. Journal of Organic Chemistry 58:5605-5606.
11. Clements CJ & Cutts FT (1995) The epidemiology of measles: thirty years of vaccination. Current Topics in Microbiology & Immunology 191:13-33.
12. Creagh T, Ruckle JL, Tolbert DT, Giltner J, Eizenhamer DA, Dutta B, Flavin MT & Xu ZQ (2001) Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects. Antimicrobial Agents & Chemotherapy 45:1379-1386.
13. Crotty S, Cameron CE & Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proceedings of the National Academy of Sciences USA 98:6895-6900.
14. Desai RD & Parghi JV (1956) Heterocyclic compounds. Part XXXI. The synthesis of partially methylated ethers of polyhydroxy coumarins. Journal of the Indian Chemical Society 33:661-664.
15. De Serres G, Gay NJ & Farrington CP (2000) Epidemiology of transmissible diseases after elimination. American Journal of Epidemiology 151:1039-1048.
16. Flavin MT, Rizzo JD, Khilevich A, Kucherenko A, Sheinkman AK, Vilaychack V, Lin L, Chen W, Greenwood EM, Pengsuparp T, Pezzuto JM, Hughes SH, Flavin TM, Cibulski M, Boulanger WA, Shone RL & Xu ZQ (1996) Synthesis, chromatographic resolution and anti-HIV activity of (±)-calanolide A and its enantiomers. Journal of Medicinal Chemistry 39:1303-1313.
17. Fox ME & Meek GA (2000) Process for the preparation of calanolide precursors. WO0064902.
18. Games DE & Haskins NJ (1971) Synthesis of some dimethylpyrano- and 3-methylbut-2-enyl-4-phenyl- and -4-n-propylcoumarins. Journal of the Chemical Society, Chemical Communications 1005-1006.
19. Gay NJ (2000) Eliminating measles-no quick fix. Bulletin of the World Health Organization 78:949.
20. Griffin, DE & Bellini WJ (1996) Measles virus. In Virology, vol. 3; pp. 1267-1312. Edited BN Fields, DM Knipe & PM Howley. Philadelphia: Lippincott-Raven.
21. Gururangan S, Stevens RF & Morris DJ (1990) Ribavirin response in measles pneumonia. Journal of Infection 20:219-221.
22. Josephy PD & Damme AV (1984) Reaction of Gibbs reagent with para-substituted phenols. Analytical Chemistry 56:813-814.
23. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A & Wakefield A (2000) Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Digestive Diseases & Sciences 45:723-729.
24. Khilevich A, Mar A, Flavin MT, Rizzo JD, Dzekhtser S, Brankovic D, Lin L, Zhang H, Chen W, Liao S, Zembower DE & Xu ZQ (1996) Synthesis of (+)-calanolide A, An anti-HIV agent, via enzyme-catalyzed resolution of the aldol products. Tetrahedron: Asymmetry 7:3315-3326.
25. Manchester M, Naniche D & Stehle T (2000) CD46 as a measles receptor: form follows function. Virology 274:5-10.
26. Marttila J, Hinkkanen A, Ziegler T, Vainionpaa R, Salmi A & Ilonen J (2001) Cell membrane-associated measles virus components inhibit antigen processing. Virology 279:422-428.
27. Martyanov IV, Zakharova OD, Sottofattori E, Pyshnyi DV, Yurchenko EY, Babbi P, Mazzei M, Balbi A, Andreola ML, Litvak S, Tarrago-Litvak L & Nevinsky GA (1999) Interaction of oligonucleotides conjugated to substituted chromones and coumarins with HIV-1 reverse transcriptase. Antisense & Nucleic Acid Drug Development 9:473-480.
28. McKee TC, Fuller RW, Covington CD, Cardellina JH 2nd, Gulakowski RJ, Krepps BL, McMahon JB & Boyd MR (1996) New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii. Journal of Natural Products 59:754-758.
29. Pengsuparp T, Serit M, Hughes SH, Soejarto DD & Pezzuto JM (1999) Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of Calophyllum teysmannii. Journal of Natural Products 59:839-842.
30. Prichard MN & Shipman C Jr (1990) A three-dimensional model to analyze drug-drug interactions. Antiviral Research 14:181-206.
31. Rota JS, Rota PA, Redd SB, Redd SC, Pattamadilok S & Bellini WJ (1998) Genetic analysis of measles viruses isolated in the United States, 1995-1996. Journal of Infectious Diseases 177:204-208.
32. Sekiguchi J, Stivers JT, Mildvan AS & Shuman S (1996) Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin. Journal of Biological Chemistry 271:2313-2322.
33. Semple SJ, Nobbs SF, Pyke SM, Reynolds GD & Flower RL (1999) Antiviral flavonoid from Pterocaulon sphacelatum, an Australian Aboriginal medicine. Journal of Ethnopharmacology 68:283-288.
34. Skulnick HI, Johnson PD, Aristoff PA, Morris JK, Lovasz KD, Howe WJ, Watenpaugh KD, Janakiraman MN, Anderson DJ, Reischer RJ, Schwartz TM, Banitt LS, Tomich PK, Lynn JC, Horng M-M, Chong K-T, Hinshaw RR, Dolak LA, Seest EP, Schwende FJ, Rush BD, Howard GM, Toth LN, Wilkinson KR, Kakuk TJ, Johnson CW, Cole SL, Zaya RM, Zipp GL, Possert PL, Dalga RJ, Zhong W-Z, Williams MG & Romines KR (1997) Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. Journal of Medicinal Chemistry 40:1149-1164.
35. Steingart KR, Thomas AR, Dykewicz CA & Redd SC (1999) Transmission of measles virus in healthcare settings during a community wide outbreak. Infection Control & Hospital Epidemiology 20:1195-1199.
36. Stogner SW, King JW, Black-Payne C & Bocchini J (1993) Ribavirin and intravenous immune globulin therapy for measles pneumonia in HIV infection. Southern Medical Journal 86:1415-1418.
37. Takeda M, Sakaguchi T, Li Y, Kobune F, Kato A & Nagai Y (1999) The genome nucleotide sequence of a contemporary wild strain of measles virus and its comparison with the classical Edmonston strain genome. Virology 256:340-350.
38. Wyde PR, Moore-Poveda DK, De Clercq E, Neyts J, Matsuda A, Minakawa N, Guzman E & Gilbert BE (2000) Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections. Antimicrobial Agents and Chemotherapy 44:1146-1152.
39. Xie L, Takeuchi Y, Cosentino LM & Lee KH (1999) Anti-AIDS agents. 37. Synthesis and structure-activity relationships of (3′R,4′R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agents. Journal of Medicinal Chemistry 42:2662-2672.
40. Xie L, Takeuchi Y, Cosentino LM, McPhail A & Lee KH (2001) Anti-AIDS agents. 42. Synthesis and anti-HIV activity of disubstituted (3′R,4′R)-3′,4′-di-O-(S)-camphanoyl-(+)- cis-khellactone analogues. Journal of Medicinal Chemistry 44:664-671.
41. Yang EB, Zhao YN, Zhang K & Mack P (1999) Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochemical and Biophysical Research Communications 260:682-685.
42. Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne GW, Pommier Y & Burke TR Jr (1997) Coumarin-based inhibitors of HIV integrase. Journal of Medicinal Chemistry 40:242-249.